Paper8554206
United Kingdom Prospective Diabetes Study 17: a 9-year update of a randomized, controlled trial on the effect of improved metabolic control on complications in non-insulin-dependent diabetes mellitus.
Turner R and 2 others. Ann Intern Med, 1996. Cited by 379 papers, by iCite.
Cite this record
ConductScience Library. United Kingdom Prospective Diabetes Study 17: a 9-year update of a randomized, controlled trial on the effect of improved metabolic control on complications in non-insulin-dependent diabetes mellitus. Papers, record 8554206. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/8554206
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- United Kingdom Prospective Diabetes Study 17: a 9-year update of a randomized, controlled trial on the effect of improved metabolic control on complications in non-insulin-dependent diabetes mellitus.
- PubMed
- Publication types
- Clinical Trial, Journal Article, Multicenter Study, Randomized Controlled Trial, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, P.H.S.
- PubMed
Topics18
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Blood Glucose | Major topic |
| Diabetes Mellitus, Type 2 | Major topic |
| Diabetic Angiopathies | Major topic |
| Hypoglycemic Agents | Major topic |
| Adult | |
| Body Weight | |
| Combined Modality Therapy | |
| Fasting | |
| Female | |
| Follow-Up Studies | |
| Glycated Hemoglobin | |
| Humans | |
| Hypoglycemia | |
| Islets of Langerhans | |
| Male | |
| Middle Aged | |
| Prospective Studies | |
| United Kingdom |
Source PubMed
Trials1
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
| Trial | Title | The trial lists it as | Named in the paper's record |
|---|---|---|---|
| NCT03540758 | Regulation of Endogenous Glucose Production by Central KATP Channels | Background |
Source ClinicalTrials.gov
Cited by112
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 379 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42207790 | One year of hyperglycemia in the Ins2Akita mouse does not impart changes in retinal vascular patterning. | PLoS One | 2026 | https://conductscience.org/library/papers/42207790 | PubMed |
| 40770322 | Model-based estimation of the generalized impact fraction (GIF) and population attributable fraction (PAF) for interventions targeting risk factors affecting the five-year risk of diabetic retinopathy. | BMC Public Health | 2025 | https://conductscience.org/library/papers/40770322 | PubMed |
| 40570536 | High rate of complications in a real-world cohort of youth with T2D: a multicenter analysis. | J Diabetes Complications | 2025 | https://conductscience.org/library/papers/40570536 | PubMed |
| 40140909 | Rising tide: the growing global burden and inequalities of early-onset type 2 diabetes among youths aged 15-34 years (1990-2021). | Diabetol Metab Syndr | 2025 | https://conductscience.org/library/papers/40140909 | PubMed |
| 39871817 | Striving for early effective glycaemic and weight management in type 2 diabetes: A narrative review. | Diabetes Obes Metab | 2025 | https://conductscience.org/library/papers/39871817 | PubMed |
| 39061960 | Novel Therapeutics for Type 2 Diabetes Mellitus-A Look at the Past Decade and a Glimpse into the Future. | Biomedicines | 2024 | https://conductscience.org/library/papers/39061960 | PubMed |
| 38867845 | Once-weekly insulin icodec versus once-daily long-acting insulins for type 2 diabetes mellitus: Systematic review and meta-analysis. | Metabol Open | 2024 | https://conductscience.org/library/papers/38867845 | PubMed |
| 38837240 | Metformin for preventing the progression of chronic kidney disease. | Cochrane Database Syst Rev | 2024 | https://conductscience.org/library/papers/38837240 | PubMed |
| 37789322 | Zingiber officinale rhizome extracts mediated ni nanoparticles and its promising biomedical and environmental applications. | BMC Complement Med Ther | 2023 | https://conductscience.org/library/papers/37789322 | PubMed |
| 36815723 | Prognostic factors for the development and progression of proliferative diabetic retinopathy in people with diabetic retinopathy. | Cochrane Database Syst Rev | 2023 | https://conductscience.org/library/papers/36815723 | PubMed |
| 36561089 | How a New Understanding of Drug or Drug Class Pharmacology Often Drives Drug Development: A Conversation with Steven E. Nissen, MD. | Methodist Debakey Cardiovasc J | 2022 | https://conductscience.org/library/papers/36561089 | PubMed |
| 36510180 | Attrition and social vulnerability during 2-year-long structured care in type 2 diabetes, the ERMIES randomized controlled trial. | BMC Endocr Disord | 2022 | https://conductscience.org/library/papers/36510180 | PubMed |
| 36478472 | Increased Advanced Glycation Endproducts, Stiffness, and Hardness in Iliac Crest Bone From Postmenopausal Women With Type 2 Diabetes Mellitus on Insulin. | J Bone Miner Res | 2023 | https://conductscience.org/library/papers/36478472 | PubMed |
| 36341847 | A randomized controlled trial to test the efficacy of a diabetes behavioral intervention to prevent memory decline in older blacks/African Americans with diabetes and mild cognitive impairment. | Contemp Clin Trials | 2022 | https://conductscience.org/library/papers/36341847 | PubMed |
| 35942330 | Impact of the Fasting Plasma Glucose Titration Target on the Success of Basal Insulin Titration in Insulin-Naïve Patients with Type 2 Diabetes: A Systematic Analysis. | J Diabetes Res | 2022 | https://conductscience.org/library/papers/35942330 | PubMed |
| 35058601 | Association of anthropometric parameters as a risk factor for development of diabetic retinopathy in patients with diabetes mellitus. | Eye (Lond) | 2023 | https://conductscience.org/library/papers/35058601 | PubMed |
| 34991585 | The many faces of diabetes. Is there a need for re-classification? A narrative review. | BMC Endocr Disord | 2022 | https://conductscience.org/library/papers/34991585 | PubMed |
| 34189680 | Beyond hemoglobin A1c: a videographic analysis of conversations about quality of life and treatment burden during clinical encounters for diabetes care. | Endocrine | 2021 | https://conductscience.org/library/papers/34189680 | PubMed |
| 32827219 | Reduction in saturated fat intake for cardiovascular disease. | Cochrane Database Syst Rev | 2020 | https://conductscience.org/library/papers/32827219 | PubMed |
| 32476140 | Effects of total fat intake on body fatness in adults. | Cochrane Database Syst Rev | 2020 | https://conductscience.org/library/papers/32476140 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| INS | 3630 | PubTator's text mining | https://conductscience.org/library/genes/3630 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Comments and corrections
- References
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/8554206
GET https://conductscience.org/api/papers/v1/8554206/cited_by?page=2